The global primary care POC diagnosticsmarket size is expected to reach USD 9.5 billion by 2028 registering a CAGR of 3.4% over the forecast period, according to the latest report by Reports and Data. Major factor driving market revenue growth is paradigm shift in diagnostics from centralized labs toward practitioners’ offices.

Point-of-care tests (POCTs) are testing services performed in a hospital consultation rather than in a conventional central laboratory, using small analytical instruments to analyse blood, saliva, urine, and faeces. Studies in Europe have shown that POCTs are useful in primary care.

POC diagnostics assists users in increasing productivity, simplifying processes and procedures, complying with regulatory and performance standards, and reducing staff pressure. The primary care POC diagnostics market will be driven by a combination of primary care and efficacity POC diagnostics, which will increase the field of healthcare dramatically over the forecast period.

According to estimates, the reduced cost of waiting for results saves up to USD 260 per patient. This will help patients reduce their waiting time by up to 46 minutes per patient. Such advantages are projected to boost the demand for primary care point-of-care diagnostics.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4097

POC devices must go through a lengthy approval process, which is one of the  major  factors restraining market growth. Manufacturers must effectively demonstrate that healthcare practitioners and patients can use POCT instruments and achieve outcomes that are comparable to clinical laboratory tests before they can be released for use. This can be a time-consuming method, which may hinder the growth of primary care POC diagnostic market to a certain extent.

Some Key Highlights in the Report:

• The glucose testing segment accounted for largest market share in 2020. Increasing adoption of glucose monitoring devices, expanding diabetic population, and growing awareness about keeping glucose level in check are factors that will drive the segment’s revenue growth.
• The physician’s office segment accounted for largest revenue share among the end use segments in 2020.
• Pharmacy and retail clinics segment is expected to be another fastest-growing segment. This growth is due to increase in the number of patients needing chronic disease tests at pharmacies and the availability of point-of-care testing at pharmacies and retail clinics.
• Market revenue from North America primary care POC diagnostics market is expected to grow at a significantly high rate over the forecast period due to presence of major market players in the region offering better tools for primary care settings.
• Asia Pacific region is expected to hold considerable revenue share due to initiatives taken in various governments for better access to primary care and integration of POC diagnostics into primary care settings.
• Some of the prominent players in the primary care POC diagnostics market include Roche Diagnostics, BD Biosciences, Danaher Corporation, Abbott Laboratories, Instrumentation Laboratory, bioMerieux, Siemens Healthcare, and Quidel Corporation.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4097

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global primary care POC diagnostics market on the basis of product, end use and region:

Product Outlook (Revenue, USD Billion; 2018 – 2028)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
• Cardiac Markers
• Thyroid Stimulating Hormone
• Haematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Faeces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

By End Use Outlook (Revenue, USD Billion; 2018 – 2028)

• Pharmacy & Retail Clinics
• Physician Office
• Urgent Care Clinics
• Non-practice Clinics

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/4097

Region Outlook (Revenue, USD Billion; 2018 – 2028)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Heart Attack Diagnostics Market By Test Type (Electrocardiogram, Blood Tests, Coronary Catheterization, Cardiac Computed Tomography, and Others), By Procedure (Invasive, Non-Invasive), By End-Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others), and By Region Forecast To 2028

Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Blood Tests {Liver Function Tests, Immunoassays & Nucleic Acid Tests}, Imaging Tests, Liver Biopsy), By End User (Hospitals, Clinics, Research Institutes, Diagnostic Laboratories, Others) And Region Forecasts To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com